Atlas Trials

Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies

Clinical trial NCT05991908 · RECRUITING

Trial details

NCT number
NCT05991908
Sponsor
Shanghai Jiao Tong University School of Medicine
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Start date
2023-10-19
Primary completion
2025-10-30
Enrollment
222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.